Intra-and intersubject whole blood/plasma cannabinoid ratios determined by 2-dimensional, electron impact GC-MS with cryofocusing

Clinical Chemistry

Volumn 55, Issue 6, 2009, Pages 1188-1195

  Schwilke, Eugene W ^a   Karschner, Erin L ^a   Lowe, Ross H ^a   Gordon, Ann M ^a   Cadet, Jean Lud ^b   Herning, Ronald I ^b   Huestis, Marilyn A ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b Washington State Patrol   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11 HYDROXYDRONABINOL; DRONABINOL; TETRAHYDROCANNABINOLIC ACID;

ADULT; ARTICLE; BLOOD LEVEL; CANNABIS ADDICTION; CLINICAL ARTICLE; FEMALE; HUMAN; INTERSUBJECT VARIABILITY; INTRASUBJECT VARIABILITY; MALE; MASS FRAGMENTOGRAPHY; PARAMETER; PLASMA; QUANTITATIVE ASSAY; SOLID PHASE EXTRACTION; TWO DIMENSIONAL ELECTRON IMPACT GAS CHROMATOGRAPHY MASS SPECTROMETRY WITH CRYOFOCUSING; VALIDATION PROCESS;

ADOLESCENT; ADULT; CANNABINOIDS; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 66449110512     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2008.114405     Document Type: Article

References (25)

1. Huestis MA, Henningfield JE, Cone EJ. Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana. J Anal Toxicol 1992;16: 276-282
2. Schwilke EW, Karschner EL, Lowe RH, Darwin WD, Huestis MA. Whole blood cannabinoids in daily cannabis users during seven days of monitored abstinence. From: Society of Forensic Toxicologists annual meeting; 2007 Oct 15-19; Durham, NC. Abstract nr S23.
3. McCallum NK, Eastwood ME. In vivo binding of Delta 1-tetrahydrocannabinol and cannabinol to rat serum proteins. J Pharm Pharmacol 1978;30: 384-386
4. Widman M, Agurell S, Ehrnebo M, Jones G. Binding of (+)-and (-)-delta-1- tetrahydrocannabinols and (-)-7-hydroxy-delta- 1-tetrahydrocannabinol to blood cells and plasma proteins in man. J Pharm Pharmacol 1974;26: 914-916
5. Wahlqvist M, Nilsson IM, Sandberg F, Agurell S. Binding of Delta-1-tetrahydrocannabinol to human plasma proteins. Biochem Pharmacol 1970; 19:2579-2584
6. Skopp G, Potsch L, Mauden M, Richter B. Partition coefficient, blood to plasma ratio, protein binding and short-term stability of 11-nor- Delta(9)-carboxy tetrahydrocannabinol glucuronide. Forensic Sci Int 2002;126:17-23.
7. Huestis MA, Henningfield JE, Cone EJ. Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of Delta-9-tetrahydrocannabinol (THC) and 11-nor-9- carboxy-Delta-9- tetrahydrocannabinol (THCCOOH). J Anal Toxicol 1992;16:283-290
8. Huestis MA, Barnes A, Smith ML. Estimating the time of last cannabis use from plasma Delta9- tetrahydrocannabinol and 11-nor-9-carboxy- Delta9-tetrahydrocannabinol concentrations. Clin Chem 2005;51:2289-2295 (Pubitemid 41692572)
9. Huestis MA, Elsohly M, Nebro W, Barnes A, Gustafson RA, Smith ML. Estimating time of last oral ingestion of cannabis from plasma THC and THCCOOH concentrations. Ther Drug Monit 2006; 28:540-544 (Pubitemid 44181488)
10. Owens SM, McBay AJ, Reisner HM, Perez- Reyes M. 125I radioimmunoassay of Delta-9- tetrahydrocannabinol in blood and plasma with a solid-phase second-antibody separation method. Clin Chem 1981;27:619-624 (Pubitemid 11109764)
11. Giroud C, Menetrey A, Augsburger M, Buclin T, Sanchez-Mazas P, Mangin P. Delta9-THC, 11-OHDelta9- THC and Delta9-THCCOOH plasma or serum to whole blood concentrations distribution ratios in blood samples taken from living and dead people. Forensic Sci Int 2001;123:159-164 (Pubitemid 33122035)
12. Lowe RH, Karschner EL, Schwilke EW, Barnes AJ, Huestis MA. Simultaneous quantification of Delta-9- tetrahydrocannabinol (THC), 11-hydroxy-Delta-9- tetrahydrocannabinol (11-OH-THC), and 11-nor-Delta- 9-tetrahydrocannabinol-9- carboxylic acid (THCCOOH) in human plasma using two-dimensional gas chromatography, cryofocusing, and electron impact-mass spectrometry. J Chromatogr A 2007;1163:318-327 (Pubitemid 47247721)
13. Krouwer JS, Rabinowitz R. How to improve estimates of imprecision. Clin Chem 1984;30:290-292 (Pubitemid 14190285)
14. Moore C, Rana S, Coulter C, Feyerherm F, Prest H. Application of two-dimensional gas chromatography with electron capture chemical ionization mass spectrometry to the detection of 11-nor- Delta9-tetrahydrocannabinol-9- carboxylic acid (THC-COOH) in hair. J Anal Toxicol 2006;30: 171-177 (Pubitemid 44285274)
15. Moore C, Coulter C, Rana S, Vincent M, Soares J. Analytical procedure for the determination of the marijuana metabolite 11-nor-Delta9- tetrahydrocannabinol-9-carboxylic acid in oral fluid specimens. J Anal Toxicol 2006;30:409-412 (Pubitemid 44371480)
16. Marin SJ, Coles R, Urry FM, McMillin GA. Confirmation of cannabinoids in meconium using two-dimensional gas chromatography with mass spectrometry detection. J Chromatogr B 2007; 858:59-64. (Pubitemid 47513611)
17. Scurlock RD, Ohlson GB, Worthen DK. The detection of Delta9- tetrahydrocannabinol (THC) and 11-nor-9- carboxy-Delta9-tetrahydrocannabinol (THCA) in whole blood using two-dimensional gas chromatography and EI-mass spectrometry. J Anal Toxicol 2006;30:262-266 (Pubitemid 44285267)
18. Agurell S, Halldin M, Lindgren JE, Ohlsson A, Widman M, Gillespie H, Hollister L. Pharmacokinetics and metabolism of Deltatetrahydrocannabinol and other cannabinoids with emphasis on man. Pharmacol Rev 1986; 38:21-43.
19. Roth KDW, Siegel NA, Johnson RW, Litauszki L, Salvati L Jr, Harrington CA, Wray LK. Investigation of the effects of solution composition and container material type on the loss of 11-nor- Delta-9-THC-9-carboxylic acid. J Anal Toxicol 1996;20:291-300. (Pubitemid 26301184)
20. Blanc JA, Manneh VA, Ernst R, Berger DE, de Keczer SA, Chase C, et al. Adsorption losses from urine-bases cannabinoid calibrators during routine use. Clin Chem 1993;39:1705-1717 (Pubitemid 23967782)
21. Schwilke EW, Karschner EL, Lowe RH, Darwin WD, Huestis MA. Whole blood/plasma cannabinoid ratios in daily cannabis users after multiple years of frozen storage. Washington, DC: American Association of Forensic Sciences, 2008:K55.
22. Johnson JR, Jennison TA, Peat MA, Foltz RL. Stability of Delta-9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC in blood and plasma. J Anal Toxicol 1984;8:202-204 (Pubitemid 14035342)
23. Wong AS, Orbanosky MW, Reeve VC, Beede JD. Stability of Delta-9-tetrahydrocannabinol in stored blood and serum. Anal Cannabinoids Res Monogr. Rockville, MD: National Institute on Drug Abuse, 1982:119-124
24. Christophersen AS. Tetrahydrocannabinol stability in whole blood: plastic versus glass containers. J Anal Toxicol 1986;10:129-131 (Pubitemid 17100544)
25. Skopp G, Potsch L. Stability of 11-nor-Delta(9)- carboxy- tetrahydrocannabinol glucuronide in plasma and urine assessed by liquid chromatography-tandem mass spectrometry. Clin Chem 2002;48:301-306